Pathophysiology of pulmonary hypertension in acute lung injury.

Acute lung injury (ALI) and acute respiratory distress syndrome are characterized by protein rich alveolar edema, reduced lung compliance, and acute severe hypoxemia. A degree of pulmonary hypertension (PH) is also characteristic, higher levels of which are associated with increased morbidity and mortality. The increase in right ventricular (RV) afterload causes RV dysfunction and failure in some patients, with associated adverse effects on oxygen delivery. Although the introduction of lung protective ventilation strategies has probably reduced the severity of PH in ALI, a recent invasive hemodynamic analysis suggests that even in the modern era, its presence remains clinically important. We therefore sought to summarize current knowledge of the pathophysiology of PH in ALI.

[1]  Horst Olschewski,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[2]  B. Thompson,et al.  Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance* , 2012, Critical care medicine.

[3]  J. Granton,et al.  Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. , 2011, American journal of respiratory and critical care medicine.

[4]  A. Rahmouni,et al.  Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. , 2011, American journal of respiratory and critical care medicine.

[5]  E. Foster,et al.  Clinical significance of elevated B-type natriuretic peptide in patients with acute lung injury with or without right ventricular dilatation: an observational cohort study , 2011, Annals of intensive care.

[6]  D. Talmor,et al.  Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. , 2011, Chest.

[7]  M. Moss,et al.  Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury. , 2010, American journal of respiratory and critical care medicine.

[8]  J. Wetterslev,et al.  Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). , 2010, The Cochrane database of systematic reviews.

[9]  E. Swart,et al.  Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS , 2009, Intensive Care Medicine.

[10]  M. Matthay,et al.  Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. , 2009, The Journal of clinical investigation.

[11]  L. Brochard,et al.  Impact of acute hypercapnia and augmented positive end-expiratory pressure on right ventricle function in severe acute respiratory distress syndrome , 2009, Intensive Care Medicine.

[12]  I. Adcock,et al.  Synergistic Induction of Endothelin-1 by Tumor Necrosis Factor α and Interferon γ Is due to Enhanced NF-κB Binding and Histone Acetylation at Specific κB Sites , 2009, The Journal of Biological Chemistry.

[13]  P. Frenette,et al.  HETEROTYPIC INTERACTIONS ENABLED BY POLARIZED NEUTROPHIL MICRODOMAINS MEDIATE THROMBO-INFLAMMATORY INJURY , 2009, Nature Medicine.

[14]  E. Mark,et al.  Interleukin-6 Overexpression Induces Pulmonary Hypertension , 2009, Circulation research.

[15]  M. Siegel,et al.  Randomized clinical trial of activated protein C for the treatment of acute lung injury. , 2008, American journal of respiratory and critical care medicine.

[16]  E. Chilvers,et al.  Advances in neutrophil biology: clinical implications. , 2008, Chest.

[17]  R. Chambers Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? , 2008, British journal of pharmacology.

[18]  N. Maniatis,et al.  The endothelium in acute lung injury/acute respiratory distress syndrome , 2008, Current opinion in critical care.

[19]  N. Anguel,et al.  Incidence and prognostic value of right ventricular failure in acute respiratory distress syndrome , 2008, Intensive Care Medicine.

[20]  A. Arner,et al.  Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction , 2008, Intensive Care Medicine.

[21]  E. Foster,et al.  Pulmonary dead space fraction and pulmonary artery systolic pressure as early predictors of clinical outcome in acute lung injury. , 2007, Chest.

[22]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[23]  G. Bernard,et al.  Acute lung injury and the acute respiratory distress syndrome: a clinical review , 2007, The Lancet.

[24]  Hsueh-Wen Chang,et al.  The Initial Response to Inhaled Nitric Oxide Treatment for Intensive Care Unit Patients with Acute Respiratory Distress Syndrome , 2007, Respiration.

[25]  John T Granton,et al.  Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[26]  T. Geiser,et al.  The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor , 2007, Thorax.

[27]  G. Iapichino,et al.  Vardenafil and Weaning from Inhaled Nitric Oxide: Effect on Pulmonary Hypertension in ARDS , 2007, Anaesthesia and intensive care.

[28]  F. Jardin,et al.  Is there a safe plateau pressure in ARDS? The right heart only knows , 2007, Intensive Care Medicine.

[29]  K. Ley,et al.  Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. , 2006, The Journal of clinical investigation.

[30]  R. Homer,et al.  Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death , 2006, Nature Medicine.

[31]  C. Ricachinevsky,et al.  Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.

[32]  B. Culver,et al.  Respiratory Physiology: The Essentials, 7th edition. , 2006 .

[33]  R. Kondo,et al.  Neutrophil cytoskeletal rearrangements during capillary sequestration in bacterial pneumonia in rats. , 2006, American journal of respiratory and critical care medicine.

[34]  A. De Gaetano,et al.  Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study* , 2006, Critical care medicine.

[35]  M. Matthay,et al.  Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. , 2006, The Journal of clinical investigation.

[36]  A. Malik,et al.  Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.

[37]  T. Evans,et al.  Inhaled nitric oxide therapy in adults. , 2005, The New England journal of medicine.

[38]  M. Singer,et al.  Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil? , 2005, British journal of anaesthesia.

[39]  E. Swenson,et al.  Physiological aspects of high-altitude pulmonary edema. , 2005, Journal of applied physiology.

[40]  M. Matthay,et al.  Differential effects of sustained inflation recruitment maneuvers on alveolar epithelial and lung endothelial injury* , 2005, Critical care medicine.

[41]  C. Hanson,et al.  Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution , 1994, Intensive Care Medicine.

[42]  C. Hanson,et al.  Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution , 1994, Intensive Care Medicine.

[43]  P. Radermacher,et al.  Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS , 2005, Intensive Care Medicine.

[44]  P. Parsons,et al.  Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[45]  L. Shekerdemian,et al.  Endothelin-A Receptor Blockade and Inhaled Nitric Oxide in a Porcine Model of Meconium Aspiration Syndrome , 2004, Pediatric Research.

[46]  C. Roussos,et al.  Pulmonary endothelium in acute lung injury: from basic science to the critically ill , 2004, Intensive Care Medicine.

[47]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[48]  M. Matthay,et al.  Plasma protein C levels in patients with acute lung injury: Prognostic significance , 2004, Critical care medicine.

[49]  Robert W. Taylor,et al.  Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. , 2004, JAMA.

[50]  A. Goetz,et al.  Platelet-endothelial cell interaction in pulmonary microcirculation: the role of PARS , 2004, Thrombosis and Haemostasis.

[51]  M. Matthay,et al.  Protein C and thrombomodulin in human acute lung injury. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[52]  C. Mélot,et al.  Endothelin receptor blockade in canine oleic acid-induced lung injury , 2003, Intensive Care Medicine.

[53]  R. Rossaint,et al.  Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. , 2003, American journal of respiratory and critical care medicine.

[54]  Chadi I. Yaacoub,et al.  Alarming hypoxemia during one-lung ventilation in a patient with respiratory bronchiolitis-associated interstitial lung disease , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[55]  E. Russi,et al.  Long-term assessment of lung function in survivors of severe ARDS. , 2003, Chest.

[56]  O. Kemmotsu,et al.  Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. , 2003, Thrombosis research.

[57]  W. Seeger,et al.  Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial , 2002, The Lancet.

[58]  T. van der Poll,et al.  Endothelium: Interface between coagulation and inflammation , 2002, Critical care medicine.

[59]  R. Naeije,et al.  Importance of hypoxic vasoconstriction in maintaining oxygenation during acute lung injury , 2002, Critical care medicine.

[60]  Rian,et al.  PULMONARY DEAD-SPACE FRACTION AS A RISK FACTOR FOR DEATH IN THE ACUTE RESPIRATORY DISTRESS SYNDROME , 2002 .

[61]  S. Dudek,et al.  Cytoskeletal regulation of pulmonary vascular permeability. , 2001, Journal of applied physiology.

[62]  F. Jardin,et al.  Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: Incidence, clinical implications, and prognosis , 2001, Critical care medicine.

[63]  C. Sartori,et al.  High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary Pressure , 2001, Circulation.

[64]  T. Evans,et al.  Influence of direct and indirect etiology on acute outcome and 6-month functional recovery in acute respiratory distress syndrome. , 2001, Critical care medicine.

[65]  J. West Invited review: pulmonary capillary stress failure. , 2000, Journal of applied physiology.

[66]  U. Dafni,et al.  Pulmonary Capillary Endothelium-Bound Angiotensin-Converting Enzyme Activity in Acute Lung Injury , 2000, Circulation.

[67]  M. Tsokos,et al.  Immunohistochemical expression of E-selectin in sepsis-induced lung injury , 2000, International Journal of Legal Medicine.

[68]  R. McIntyre,et al.  Thirty years of clinical trials in acute respiratory distress syndrome , 2000, Critical care medicine.

[69]  J. Tomashefski Pulmonary pathology of acute respiratory distress syndrome. , 2000, Clinics in chest medicine.

[70]  A. Bindels,et al.  Right ventricular failure in acute respiratory distress syndrome. , 2000, The Netherlands journal of medicine.

[71]  P. V. Ichinsky,et al.  Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease , 2000 .

[72]  P. V. van Heerden,et al.  Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. , 2000, Chest.

[73]  E. Vichinsky,et al.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. , 2000, The New England journal of medicine.

[74]  L. McIntire,et al.  Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells. , 2000, Blood.

[75]  W. Hurford,et al.  Inhaled nitric oxide: basic biology and clinical applications. , 1999, Anesthesiology.

[76]  Ju-Yi Chen,et al.  Effect of Meconium Aspiration on Plasma Endothelin-1 Level and Pulmonary Hemodynamics in a Piglet Model , 1999, Neonatology.

[77]  W. Kuebler,et al.  Pressure is proinflammatory in lung venular capillaries. , 1999, The Journal of clinical investigation.

[78]  R. Rossaint,et al.  Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with acute respiratory distress syndrome , 1999, Intensive Care Medicine.

[79]  D. Schuster,et al.  Response to inhaled nitric oxide in acute lung injury depends on distribution of pulmonary blood flow prior to its administration. , 1999, American journal of respiratory and critical care medicine.

[80]  Wort Sj,et al.  The role of the endothelium in modulating vascular control in sepsis and related conditions. , 1999 .

[81]  T. Evans,et al.  The role of the endothelium in modulating vascular control in sepsis and related conditions. , 1999, British medical bulletin.

[82]  A. Pohlman,et al.  Response to inhaled nitric oxide in patients with acute right heart syndrome. , 1999, American journal of respiratory and critical care medicine.

[83]  J. Zimmerman,et al.  Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. , 1998, Critical care medicine.

[84]  D. Hansell,et al.  Clinical correlates in acute lung injury: response to inhaled nitric oxide. , 1998, Chest.

[85]  J. Carlet,et al.  Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study , 1998, Intensive Care Medicine.

[86]  J. Dhainaut,et al.  Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. , 1998, American journal of respiratory and critical care medicine.

[87]  K. Domino,et al.  Effects of posture on blood flow diversion by hypoxic pulmonary vasoconstriction in dogs. , 1998, British journal of anaesthesia.

[88]  L. Berggren,et al.  Pulmonary function in adult survivors of severe acute lung injury treated with inhaled nitric oxide , 1998, Acta anaesthesiologica Scandinavica.

[89]  M. Booke,et al.  Inhaled Prostaglandin E1 for Treatment of Acute Lung Injury in Severe Multiple Organ Failure , 1998, Anesthesia and analgesia.

[90]  T. Evans,et al.  Comparison of nose and face mask CPAP therapy for sleep apnoea , 1998, Thorax.

[91]  T. Evans,et al.  Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome. , 1998, American journal of respiratory and critical care medicine.

[92]  M. Uchiba,et al.  Antithrombin III (AT III) Prevents LPS-Induced Pulmonary Vascular Injury: Novel Biological Activity of AT III , 1997, Seminars in thrombosis and hemostasis.

[93]  K. Geiger,et al.  Large increase in cardiac output in a patient with ARDS and acute right heart failure during inhalation of nitric oxide , 1997, Acta anaesthesiologica Scandinavica.

[94]  J. T. Owings,et al.  Acquired antithrombin deficiency following severe traumatic injury: rationale for study of antithrombin supplementation. , 1997, Seminars in thrombosis and hemostasis.

[95]  J. Harenberg,et al.  Monoclonal Antibodies against Heparin and Heparinoids , 1997, Seminars in thrombosis and hemostasis.

[96]  K. Takatsuki,et al.  Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation. , 1997, The American journal of physiology.

[97]  M. Haller,et al.  Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[98]  R. Naeije,et al.  Effects of hypoxic pulmonary vasoconstriction on pulmonary gas exchange. , 1996, Journal of applied physiology.

[99]  H. Isobe,et al.  RECOMBINANT THROMBOMODULIN PREVENTS ENDOTOXIN‐INDUCED LUNG INJURY IN RATS BY INHIBITING LEUKOCYTE ACTIVATION: 227 , 1996 .

[100]  R. Shenkar,et al.  Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. , 1996, Critical care medicine.

[101]  R. McIntyre,et al.  Impact of respiratory acid-base status in patients with pulmonary hypertension. , 1996, The Annals of thoracic surgery.

[102]  D. Faller,et al.  Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. , 1995, The Journal of clinical investigation.

[103]  A Giaid,et al.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.

[104]  J. Dhainaut,et al.  Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. , 1995, American journal of respiratory and critical care medicine.

[105]  P. Barnes,et al.  Regulation of pulmonary vascular tone. , 1995, Pharmacological reviews.

[106]  T. Dahms,et al.  Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. , 1995, American journal of respiratory and critical care medicine.

[107]  T. Evans,et al.  In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. , 1995, The American journal of physiology.

[108]  R. Strieter,et al.  Acute lung injury: the role of cytokines in the elicitation of neutrophils. , 1994, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[109]  T. Evans,et al.  Pulmonary endothelial permeability in patients with severe lung injury. Clinical correlates and natural history. , 1994, Chest.

[110]  J. Stamler,et al.  Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. , 1994, Circulation.

[111]  R. Kacmarek,et al.  Prolonged Inhalation of Low Concentrations of Nitric Oxide in Patients with Severe Adult Respiratory Distress Syndrome: Effects on Pulmonary Hemodynamics and Oxygenation , 1994, Anesthesiology.

[112]  B. Freeman Free radical chemistry of nitric oxide. Looking at the dark side. , 1994, Chest.

[113]  H. Adams,et al.  EFFECTS OF CYTOKINES TUMOR NECROSIS FACTOR α AND INTERLEUKIN 1β ON ENDOTOXIN‐MEDIATED INHIBITION OF ENDOTHELIUM‐DERIVED RELAXING FACTOR BIOACTIVITY AND NITRIC OXIDE PRODUCTION IN VASCULAR ENDOTHELIUM , 1994, Shock.

[114]  D. Laporta,et al.  Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. , 1993, The American review of respiratory disease.

[115]  K. Lenz,et al.  Endothelin-1 in adult respiratory distress syndrome. , 1993, The American review of respiratory disease.

[116]  W. Seeger,et al.  Aerosolised prostacyclin in adult respiratory distress syndrome , 1993, The Lancet.

[117]  J. Hogg,et al.  Comparison of neutrophil and capillary diameters and their relation to neutrophil sequestration in the lung. , 1993, Journal of applied physiology.

[118]  M. Blaustein,et al.  Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. , 1993, The American journal of physiology.

[119]  T. Hurst,et al.  Insufflated halothane increases venous admixture less than nitroprusside in canine atelectasis. , 1992, Anesthesiology.

[120]  R. Sánchez,et al.  Comparative study between the effects of total intravenous anesthesia with propofol and balanced anesthesia with halothane on the alveolar-arterial oxygen tension difference and on the pulmonary shunt. , 1992, Archives of medical research.

[121]  G. Bernard,et al.  Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. , 1991, The American review of respiratory disease.

[122]  A. Redington,et al.  Doppler echocardiographic evaluation of pulmonary blood flow after the Fontan operation: the role of the lungs. , 1991, British heart journal.

[123]  D. Crawley,et al.  Endogenous nitric oxide modulates adrenergic neural vasoconstriction in guinea‐pig pulmonary artery , 1991, British journal of pharmacology.

[124]  T. Martin,et al.  Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. , 1991, The American journal of physiology.

[125]  C. Mélot,et al.  PEEP inhibits hypoxic pulmonary vasoconstriction in dogs. , 1991, Journal of applied physiology.

[126]  D. Green,et al.  Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. , 1990, The Journal of clinical investigation.

[127]  C. Mélot,et al.  Inhibition of hypoxic pulmonary vasoconstriction by increased left atrial pressure in dogs. , 1990, The American journal of physiology.

[128]  F. Lemaire,et al.  Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. , 1990, The New England journal of medicine.

[129]  C. Mélot,et al.  Effects of acidosis and alkalosis on hypoxic pulmonary vasoconstriction in dogs. , 1990, The American journal of physiology.

[130]  J. Sadler,et al.  Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. , 1989, The Journal of biological chemistry.

[131]  L. Bjertnaes,et al.  Interaction of verapamil and halogenated inhalation anesthetics on hypoxic pulmonary vasoconstriction. , 1989, Acta anaesthesiologica Scandinavica.

[132]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[133]  W. Zapol,et al.  Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy. , 1987, AJR. American journal of roentgenology.

[134]  C. Francis,et al.  Fibrin induces release of von Willebrand factor from endothelial cells. , 1987, The Journal of clinical investigation.

[135]  C. N. Gillis,et al.  Depressed prostaglandin E1 and 5-hydroxytryptamine removal in patients with adult respiratory distress syndrome. , 1986, The American review of respiratory disease.

[136]  B. Meyrick,et al.  Repeated Escherichia coli endotoxin-induced pulmonary inflammation causes chronic pulmonary hypertension in sheep. Structural and functional changes. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[137]  K. Kubo,et al.  [Hypoxic pulmonary vasoconstriction]. , 1985, Kokyu to junkan. Respiration & circulation.

[138]  P. Guéret,et al.  Two‐dimensional echocardiographic evaluation of right ventricular size and contractility in acute respiratory failure , 1985, Critical care medicine.

[139]  J. Tomashefski,et al.  The pulmonary vascular lesions of the adult respiratory distress syndrome. , 1983, The American journal of pathology.

[140]  W. Sibbald,et al.  Pulmonary accumulation of polymorphonuclear leukocytes in the adult respiratory distress syndrome , 1982, Critical care medicine.

[141]  W. Zapol,et al.  Pulmonary vascular remodeling in adult respiratory distress syndrome. , 1982, The American review of respiratory disease.

[142]  W. Zapol,et al.  Acute Pulmonary Hypertension and Lung Thromboxane Release after Endotoxin Infusion in Normal and Leukopenic Sheep , 1982, Circulation research.

[143]  S. Oparil,et al.  Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: A preliminary report , 1981, Critical care medicine.

[144]  A. Morris,et al.  Pulmonary function and exercise gas exchange in survivors of adult respiratory distress syndrome. , 1981, The American review of respiratory disease.

[145]  H. Redl,et al.  Electron-microscopic investigation of lung biopsies in patients with post-traumatic respiratory insufficiency. , 1980, Acta chirurgica Scandinavica. Supplementum.

[146]  W. Zapol,et al.  Pulmonary hypertension in severe acute respiratory failure. , 1977, The New England journal of medicine.

[147]  J. Benumof,et al.  Dependency of hypoxic pulmonary vasoconstriction on temperature. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.

[148]  R. Bone,et al.  Intravascular coagulation associated with the adult respiratory distress syndrome. , 1976, The American journal of medicine.

[149]  John F. Nunn,et al.  Respiratory Physiology—the essentials , 1975 .

[150]  J. Reeves,et al.  Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. , 1972, The Journal of clinical investigation.

[151]  T L Petty,et al.  Acute respiratory distress in adults. , 1967, Lancet.

[152]  T. Saldeen BLOOD COAGULATION AND SHOCK. , 1979, British medical journal.

[153]  D. Shelton,et al.  Vascular Obstruction Causes Pulmonary Hypertension in Severe Acute Respiratory Failure , 2022 .